Researchers have demonstrated that the gene-editing system CRISPR can be reprogrammed as a precision weapon against cancer, selectively destroying diseased cells while leaving healthy tissue intact. The findings, published in the journal Nature, represent a fundamental expansion of what CRISPR technology can accomplish in medicine.
The team at Utah State University, led by biochemist Kang Hyun Yi, showed that a variant called CRISPR-Cas12a2 can be programmed to recognize specific RNA sequences found in unhealthy cells. Once activated, the system doesn't simply edit a gene—it triggers a controlled destruction of the entire cell, a process known as collateral cleavage that degrades cellular nucleic acids until the cell dies.
In mouse models, a single treatment reduced tumor volume by approximately 50%. Crucially, healthy cells surrounding the tumors were spared, addressing one of oncology's most persistent challenges: how to attack cancer without causing the devastating collateral damage associated with chemotherapy and radiation.
The specificity comes from guide RNA sequences that direct Cas12a2 to recognize molecular signatures unique to cancer cells. Different tumors express different RNA profiles, meaning the system could theoretically be customized for individual patients' cancers—a form of truly personalized medicine that has long been the goal of precision oncology.
This represents a significant conceptual shift for CRISPR. The technology gained fame as a gene editor—a tool for cutting and modifying specific DNA sequences. Using it as a cellular assassin that targets cells for destruction based on their RNA expression patterns is a fundamentally different application that vastly expands the therapeutic potential.
The Cas12a2 variant differs from the better-known Cas9 in important ways. While Cas9 makes precise cuts in DNA, Cas12a2 exhibits what researchers call "collateral cleavage activity"—once activated by its target RNA, it indiscriminately degrades nearby nucleic acids. In a test tube, this property is a nuisance. In a cancer cell, it's a feature: the activated enzyme systematically destroys the cell's genetic material, ensuring cell death.
